Mobile Endoscopic Workstations Market

Market Definition

The market includes compact, portable systems designed to support endoscopic procedures in surgical, diagnostic, and emergency care settings. These workstations integrate components such as monitors, light sources, insufflators, and recording systems into a mobile platform. They allow for efficient setup, real-time imaging, and streamlined workflows in operating rooms or outpatient clinics. 

Applications span gastroenterology, urology, pulmonology, and ENT procedures. These systems are formulated to ensure hygiene, portability, and compatibility with a range of endoscopic tools. The report provides a comprehensive analysis of key drivers, emerging trends, and the competitive landscape expected to influence the market over the forecast period.

Mobile Endoscopic Workstations Market Overview

The global mobile endoscopic workstations market size was valued at USD 314.3 million in 2024 and is projected to grow from USD 326.4 million in 2025 to USD 428.7 million by 2032, exhibiting a CAGR of 3.94% during the forecast period. 

Market growth is driven by rising demand in ambulatory surgical centers, where compact and mobile systems improve procedural efficiency. Additionally, advancements in endoscopic imaging technology are enhancing diagnostic accuracy and surgical precision, prompting healthcare facilities to invest in integrated, flexible workstation solutions.

Major companies operating in the mobile endoscopic workstations industry are Olympus Corporation, Karl Storz SE & Co. KG, Ambu A/S, Getinge AB, B. Braun, ARC Group of Companies Inc., Cura Carts, Electro Kinetic Technologies, EMOS Technology GmbH, GIMMI GmbH, Haeberle GmbH & Co. KG, Armstrong Medical Inc., Ecleris, PHS West, and Optomic.

The rise in minimally invasive surgeries across gastroenterology, pulmonology, and ENT specialties is contributing significantly to market expansion. Surgeons and hospitals are adopting mobile platforms to optimize workflow, reduce setup time, and support patient mobility during procedures. 

These systems allow seamless integration of imaging and recording devices, which supports precision during surgeries. The demand for compact, adaptable, and portable technologies further supports market expansion.

• In October 2023, Olympus introduced the EVIS X1 endoscopy system in the U.S., featuring advanced imaging technologies such as Texture and Color Enhancement Imaging (TXI), Red Dichromatic Imaging (RDI), and Brightness Adjustment Imaging with Maintenance of Contrast (BAI-MAC). These enhancements aim to improve lesion and polyp detection during gastrointestinal procedures.

Key Highlights

1. The mobile endoscopic workstations industry size was valued at USD 314.3 million in 2024.
2. The market is projected to grow at a CAGR of 3.94% from 2025 to 2032.
3. North America held a market share of 34.09% in 2024, with a valuation of USD 107.1 million.
4. The gastrointestinal endoscopes segment garnered USD 76.1 million in revenue in 2024.
5. The hospitals segment is expected to reach USD 141.2 million by 2032.
6. Asia Pacific is anticipated to grow at a CAGR of 4.90% during the forecast period.

Market Driver

Growing Demand in Ambulatory Surgical Centers

The global expansion of ambulatory surgical centers (ASCs) worldwide is fueling the growth of the mobile endoscopic workstations market. ASCs require space-efficient, mobile systems that can be easily transferred between surgical rooms without compromising imaging or equipment access. These workstations support a wide range of outpatient procedures, offering versatility for multiple specialties. 

The demand from ASCs for cost-effective and compact setups is increasing, prompting manufacturers to introduce tailored solutions that align with operational efficiency goals.

• In August 2024, ChristianaCare and Atlas Healthcare Partners formed a joint venture to develop over 10 ASCs across Delaware, Maryland, New Jersey, and Pennsylvania within five years. This strategic partnership aims to expand access to outpatient surgical care in the Mid-Atlantic region.

Market Challenge

High Initial Investment and Maintenance Costs

A significant challenge limiting the growth of the mobile endoscopic workstations market is the high upfront cost and ongoing maintenance expenses associated with advanced systems. These costs can be restrictive, specifically for smaller hospitals and clinics.

To address this challenge, key players are offering modular workstation designs that allow gradual upgrades, reducing immediate capital pressure. Some players are introducing leasing models and flexible financing options to support budget-limited facilities. 

Additionally, manufacturers are improving system durability and offering extended service contracts to minimize long-term maintenance burdens, making mobile endoscopic workstations more accessible to a wider range of healthcare providers.

Market Trend

Advancements in Endoscopic Imaging Technology

Continuous innovations in endoscopic imaging systems, including 4K resolution, enhanced lighting, and integrated video processing, are emerging as a key trend in the mobile endoscopic workstations market. These technological upgrades require robust and mobile platforms to host high-performance components. 

Workstations are evolving to support advanced video capture, real-time diagnostics, and seamless connectivity with hospital IT systems. With the surging demand for clinical imaging, medical facilities increasingly require compatible and future-ready mobile units.

• In September 2024, Olympus Corporation launched the CH-S700-08-LB 4K camera head for endoscopic urology and gynecology procedures in Europe. Compatible with the VISERA ELITE III video system, this device offers 4K white light imaging, 4K Narrow Band Imaging (NBI), and Blue Light observation, enhancing visualization for early diagnosis and treatment of conditions such as non-muscle invasive bladder cancer.

Mobile Endoscopic Workstations Market Report Snapshot

Segmentation	Details
By Type	Gastrointestinal Endoscopes, Colonoscopes, Enteroscopes, Laparoscopes, Bronchoscopes, Cystoscopes, Others
By End User	Hospitals, Diagnostic Imaging Centers, Ambulatory Surgery Centers & Clinics, Specialized Endoscopy Clinics
By Region	North America: U.S., Canada, Mexico
	Europe: France, UK, Spain, Germany, Italy, Russia, Rest of Europe
	Asia-Pacific: China, Japan, India, Australia, ASEAN, South Korea, Rest of Asia-Pacific
	Middle East & Africa: Turkey, U.A.E., Saudi Arabia, South Africa, Rest of Middle East & Africa
	South America: Brazil, Argentina, Rest of South America

Market Segmentation

• By Type (Gastrointestinal Endoscopes, Colonoscopes, Enteroscopes, Laparoscopes, Bronchoscopes, Cystoscopes, and Others): The gastrointestinal endoscopes segment earned USD 76.1 million in 2024, mainly due to the high volume of gastrointestinal procedures globally and the increasing need for mobile, integrated systems that support advanced diagnostic and therapeutic endoscopy in hospital and outpatient settings.
• By End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgery Centers & Clinics, and Specialized Endoscopy Clinics): The hospitals segment held a share of 33.24% in 2024, propelled by its high procedure volume, diverse clinical applications, and strong investment in advanced medical equipment.

Mobile Endoscopic Workstations Market Regional Analysis

Based on region, the market has been classified into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

The North America mobile endoscopic workstations market share stood at around 34.09% in 2024, valued at USD 107.1 million. North America is witnessing rapid growth in outpatient surgery centers, particularly for gastroenterology, ENT, and urology procedures. The shift toward same-day procedures is increasing the demand for mobile platforms that offer flexibility, efficient setup, and reliable imaging support, contributing to regional market growth.

Moreover, North America is home to several medical device manufacturers and specialized suppliers of endoscopic systems. The availability of regionally supported mobile workstations allows hospitals to access quick technical support, custom configurations, and faster delivery, boosting domestic market progress.

• In September 2024, Olympus announced FDA clearance for the CADDIE device, the first cloud-based AI technology designed to assist gastroenterologists in detecting colorectal polyps during colonoscopy procedures. This innovation supports enhanced detection capabilities in outpatient settings, addressing the increasing demand for advanced diagnostic tools in ambulatory surgical centers.

The Asia-Pacific mobile endoscopic workstations industry is estimated to grow at a CAGR of 4.90% over the forecast period. Asia Pacific marks a rapid development of multi-specialty hospitals in major urban areas. These facilities often face space constraints and demand versatile systems that can be shared across departments. This growing preference for mobile and multifunctional setups is supporting growth in the region’s urban healthcare sector. 

Furthermore, the expansion of private healthcare providers across Asia Pacific is creating a strong demand for modern, efficient medical systems. Private hospitals are investing in mobile endoscopic workstations to optimize operating room use and reduce equipment downtime.

• In September 2024, Olympus Australia launched "Sapphire," its first flexible endoscope sterilization facility in Melbourne. As part of the Olympus On-Demand solution, it provides hospitals with ready-to-use, sterilized endoscopes. The initiative aims to reduce risks and complexities associated with endoscopy services, particularly for urban hospitals with limited space and diverse equipment needs.

Regulatory Frameworks

• The U.S. Food and Drug Administration (FDA) regulates medical devices under the Federal Food, Drug, and Cosmetic Act. Mobile endoscopic workstations are typically classified as Class II devices, requiring a 510(k) premarket notification to demonstrate substantial equivalence to a legally marketed device. Compliance with the Quality System Regulation (QSR) outlined in 21 CFR Part 820 is mandatory.
• The EU Medical Device Regulation (MDR) 2017/745 governs medical devices, replacing prior directives. Devices are classified into Classes I to III based on risk. Mobile endoscopic workstations typically require CE marking, indicating conformity with applicable standards, including IEC 60601 for electrical safety. Manufacturers must involve a Notified Body for conformity assessment and maintain a quality management system aligned with ISO 13485.
• The National Medical Products Administration (NMPA) regulates medical devices in China, classifying them into Classes I to III based on risk. Mobile endoscopic workstations typically fall under Class II or III, requiring product registration and adherence to Chinese Good Manufacturing Practices (GMP). In July 2024, the Medical Device Good Supply Practice (GSP) was introduced, emphasizing quality management standards for distributors.

Competitive Landscape

Major players in the mobile endoscopic workstations industry are adopting strategies such as launching operator-friendly and procedure-specific tools that improve precision during complex interventions. These strategies focus on reducing procedure time, enhancing visualization, and supporting advanced techniques such as Endoscopic Submucosal Dissection. 

By developing solutions that work seamlessly with existing endoscopy systems while offering independent control, companies are improving usability and clinical outcomes. This targeted innovation is fueling market growth by addressing evolving needs in gastrointestinal endoscopy.

• In April 2024, Fujifilm unveiled the Tracmotion ESD device at Endocon 2024 in Delhi. This single-operator solution features 360° rotatable retractions, allowing precise tissue manipulation independent of endoscope movement. Designed to streamline Endoscopic Submucosal Dissection (ESD) procedures, Tracmotion aims to enhance efficiency and visualization.

List of Key Companies in Mobile Endoscopic Workstations Market:

• Olympus Corporation
• Karl Storz SE & Co. KG
• Ambu A/S
• Getinge AB
• B. Braun
• ARC Group of Companies Inc.
• Cura Carts
• Electro Kinetic Technologies
• EMOS Technology GmbH
• GIMMI GmbH
• Haeberle GmbH & Co. KG
• Armstrong Medical Inc.
• Ecleris
• PHS West
• Optomic

Recent Developments (Product Launch)

• In April 2025, Fujifilm India unveiled the ELUXEO 8000 Therapeutic Endoscopy Solution at the MUMBAI LIVE Endoscopy event. This system features the latest CMOS sensor and 4K output, offering enhanced image clarity. It is designed for minimally invasive to improve diagnostic accuracy and reduce patient recovery time.